Community/Retail

Patients in the atogepant 60 mg daily and 30 mg twice daily treatment arms of the study experienced a decrease of 6.88 and 7.46 monthly migraine days, respectively.

Baricitinib (Olumiant; Eli Lilly and Incyte ) was found to produce significant hair regrowth on the scalp, eyelashes, and eyebrows of adults with severe alopecia areata.

Theraworx is a foam that offers relief from muscle cramps and spasm.

FDA seeks to reduce diversion of pharmaceutical products via sales by unlicensed distributers and tighten up the supply chain by vetting trading partners.

Students from the University of the Sciences Philadelphia College of Pharmacy and the Rutgers University Ernest Mario School of Pharmacy went head-to-head to answer questions about the pharmacy field.

Heat waves, which are on the rise, appear to pose particular cardiovascular risk for Black populations and men, new study results show.

In proposed changes, the practice would fall within nonsterile compounding.

FDA approves label update for Cabenuva that makes the therapy’s oral lead-in with cabotegravir and rilpivirine tablets optional.

RSVpreF gets breakthrough designation for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in individuals 60 years of age or older.

Most other compounds undergoing clinical trials target testosterone, which can lead to depression, higher low-density lipoprotein cholesterol levels, and weight gains.

Donepezil (Aricept) is an acetylcholinesterase inhibitor indicated for the treatment of dementia related to Alzheimer disease.

Pataday ophthalmic solution is an antihistamine that can help reduce itch and redness in the eyes.

Many of the medications used in the treatment of erectile dysfunction have interactions with other medications, so it is crucial for pharmacists to carefully examine patient profiles to optimize therapy and ensure safety.

Investigators also identified that a polymerase inhibitor with a unique modification largely resists its removal from the RNA by the exonuclease.

Thirty minutes of day of movement, such as walking, can help break the cycle of inflammation that causes symptoms even 6 months later.

Nasacort offers temporary relief of allergy symptoms, such as nasal congestion, sneezing, itchy and runny nose.

Patient-centered communication incorporates patients’ concerns, ideas, and abilities when developing a treatment plan.

The FDA recently approved cabotegravir 200 mg/mL and rilpivirine 300 mg/mL as a once-monthly treatment for adults with HIV-1 who are virologically suppressed on a stable antiretroviral regimen.

Study suggests a link between vitamin D deficiency and COVID-19 severity and mortality.

It is critical for pharmacists to inquire about the use of e-cigarette or vaping products in patients that present with certain symptoms.

Results of an excess-deaths analysis show that 18.2 million individuals have likely died as a result of the pandemic.

Medication therapy management programs enhance communication, spur innovation.

Acid controllers relieve heartburn associated with indigestion.

Previous research has shown that genetic factors contribute immensely to the risk of migraine.

Omnipod 5 allows patients with diabetes to receive 72 hours of continuous, automated insulin administration.

This month's featured products include treatments for insomnia, atopic dermatitis, and more.

Simulations of disease spread show that wearing masks for at least 2 weeks after achieving goal of a minimum of 70% population coverage saves money and reduces deaths and hospitalizations.

Asmanex HFA is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in patients 12 years of age and older

BioFreeze is a cold therapy for sore muscles, backaches, and joint pain.

Pharmacists are an important part of the care team for patients with bleeding disorders, providing services such as medication counseling and reconciliation.